Plain English summary
W e evaluated the clinical effectiveness and cost-effectiveness of radically open dialectical behaviour therapy (RO DBT), which is a new treatment for depression and problems of emotional overcontrol, such as misguided perfectionism and emotional loneliness, by comparing its effects with treatment as usual (TAU), the health care normally available from the NHS or private providers. From three dissimilar UK locations, we recruited adults who were diagnosed with major depressive disorder who had not responded to treatment and who scored above the threshold on a standard measure of current depression. We randomly assigned them to either 7 months of RO DBT (n = 162 patients) or TAU (n = 88 patients). Recently trained therapists delivered RO DBT over 29 weekly 1-hour individual therapy sessions and 27 weekly 2.5-hour skills group sessions. We reassessed patients at the end of the treatment and at 12 and 18 months after entering the study. After 12 months, the main time at which we assessed clinical effectiveness, both groups reported worthwhile reductions in depression scores; however, the difference could have occurred by chance. At the end of treatment, in contrast, RO DBT patients had reported a reduction in depressive symptoms that was much larger by both statistical and clinical criteria than that reported by TAU patients. Furthermore, more of participants reported that they no longer felt depressed. The economic analyses concluded that, although RO DBT had reduced the extent and cost of other health care, it was too costly in its current form to achieve cost-effectiveness by published criteria. Hence, the next challenge is to find ways of delivering RO DBT more efficiently and more sustainably.
